Items where authors include "Atkins, B."

Article

Scott, S. orcid.org/0000-0001-7669-0632, Martin-Kerry, J., Pritchard, M. et al. (16 more authors) (2026) The feasibility of implementing a hospital deprescribing behaviour change intervention and undertaking trial processes: a mixed methods evaluation. Research in Social and Administrative Pharmacy, 22 (2). pp. 333-339. ISSN 1551-7411

Abani, O., Abbas, A., Abbas, F. et al. (7724 more authors) (2026) Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases, 26 (1). pp. 34-45. ISSN 1473-3099

Scott, S. orcid.org/0000-0001-7669-0632, Martin-Kerry, J., Pritchard, M. et al. (16 more authors) (2025) The feasibility of implementing a hospital deprescribing behaviour change intervention and undertaking trial processes: A mixed methods evaluation. Research in Social and Administrative Pharmacy. ISSN 1551-7411 (In Press)

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Scott, S., Atkins, B., D'Costa, T. et al. (12 more authors) (2024) Development of the Guide to Disseminating Research (GuiDiR): A consolidated framework. Research in Social and Administrative Pharmacy. ISSN 1551-7411

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Scott, S. orcid.org/0000-0001-7669-0632, Atkins, B., Martin-Kerry, J.M. orcid.org/0000-0002-9299-1360 et al. (15 more authors) (2023) CompreHensive geriAtRician-led MEdication Review (CHARMER): protocol for a feasibility study of a hospital deprescribing behaviour change intervention. BMJ Open, 13. e075795. ISSN 2044-6055

Scott, S. orcid.org/0000-0001-7669-0632, Atkins, B., Martin-Kerry, J.M. orcid.org/0000-0002-9299-1360 et al. (15 more authors) (2023) CompreHensive geriAtRician-led MEdication Review (CHARMER): protocol for a feasibility study of a hospital deprescribing behaviour change intervention. BMJ Open, 13 (8). e075795. ISSN 2044-6055

Atkins, J.F., Atkins, B., Maroun, W. orcid.org/0000-0001-7448-1220 et al. (2 more authors) (2023) Conservation through conversation? Therapeutic engagement on biodiversity and extinction between NGOs and companies. Business Strategy and the Environment, 32 (5). pp. 2631-2647. ISSN 0964-4733

Atkins, J. orcid.org/0000-0001-8727-0019, Atkins, B., Maroun, W. et al. (2 more authors) (2023) Conservation through conversation? Therapeutic engagement on biodiversity and extinction between NGOs and companies. Business Strategy and the Environment, 32 (5). pp. 2631-2647. ISSN 0964-4733

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Scarborough, M., Li, H.K., Rombach, I. orcid.org/0000-0003-3464-3867 et al. (37 more authors) (2019) Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health Technology Assessment, 23 (38). ISSN 1366-5278

Atkins, J.F. orcid.org/0000-0001-8727-0019, Maroun, W., Atkins, B. et al. (1 more author) (2018) From the Big Five to the Big Four? Exploring Extinction Accounting for the Rhinoceros. Accounting, Auditing & Accountability Journal, 31 (2). pp. 674-702. ISSN 0951-3574